12:00 AM
 | 
May 24, 1999
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

SafeScience preclinical data

GBC-590 produced a significant tumor response, including complete tumor shrinkage and arrest of tumor...

Read the full 46 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >